Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

Treatment options for chronic hepatitis C virus (HCV) infection have drastically changed since the development and licensing of new potent direct-acting antivirals (DAAs). The majority of DAAs are extensively metabolized by liver enzymes and have the ability to influence cytochrome P450 (CYP) enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolders, E. J., de Kanter, C. T. M. M., de Knegt, R. J., van der Valk, M., Drenth, J. P. H., Burger, D. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107187/
https://www.ncbi.nlm.nih.gov/pubmed/27317413
http://dx.doi.org/10.1007/s40262-016-0407-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107187/
https://www.ncbi.nlm.nih.gov/pubmed/27317413
http://dx.doi.org/10.1007/s40262-016-0407-2

Ejemplares similares